Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization in the US and Europe From 2007 to 2021

IMPORTANCE: The number of drugs approved through the accelerated approval or conditional marketing authorization pathways has increased with unclear evidence of their therapeutic value. OBJECTIVES: To assess the therapeutic value of drug indications granted accelerated approval in the US or conditio...

Descripción completa

Detalles Bibliográficos
Autores principales: Vokinger, Kerstin N., Kesselheim, Aaron S., Glaus, Camille E. G., Hwang, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391955/
https://www.ncbi.nlm.nih.gov/pubmed/36200635
http://dx.doi.org/10.1001/jamahealthforum.2022.2685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391955/
https://www.ncbi.nlm.nih.gov/pubmed/36200635
http://dx.doi.org/10.1001/jamahealthforum.2022.2685

Ejemplares similares